阿来替尼相关的伴有嗜酸性粒细胞增多和全身症状的药物反应综合征。 - Suppr

Suppr

超能文献

Alectinib-associated drug reaction with eosinophilia and systemic symptoms syndrome.

作者信息

Farooq Sahira, Narala Saisindhu, Pacha Omar

机构信息

McGovern Medical School, University of Texas Health Science Center at Houston, Texas.

Department of Dermatology, University of Texas Health Science Center at Houston, Texas.

出版信息

JAAD Case Rep. 2020 Sep 11;6(12):1339-1341. doi: 10.1016/j.jdcr.2020.09.007. eCollection 2020 Dec.

DOI:10.1016/j.jdcr.2020.09.007

PMID:33304973

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7708757/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/969f/7708757/35b6884a81c9/gr1.jpg

相似文献

Alectinib-associated drug reaction with eosinophilia and systemic symptoms syndrome.

JAAD Case Rep. 2020 Sep 11;6(12):1339-1341. doi: 10.1016/j.jdcr.2020.09.007. eCollection 2020 Dec.

Drug Reaction with Eosinophilia and Systemic Symptoms: An Update and Review of Recent Literature.

Indian J Dermatol. 2018 Jan-Feb;63(1):30-40. doi: 10.4103/ijd.IJD_582_17.

Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease.

J Am Acad Dermatol. 2009 Jan;60(1):146-9. doi: 10.1016/j.jaad.2008.07.044.

Liver involvement in the drug reaction, eosinophilia, and systemic symptoms syndrome.

World J Clin Cases. 2019 Mar 26;7(6):705-716. doi: 10.12998/wjcc.v7.i6.705.

Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).

J Dermatol. 2015 Mar;42(3):276-82. doi: 10.1111/1346-8138.12770. Epub 2015 Jan 27.

Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms.

Br J Dermatol. 2016 Nov;175(5):944-952. doi: 10.1111/bjd.14677. Epub 2016 Aug 28.

Drug reaction with eosinophilia and systemic symptoms syndrome associated with Nitrofurantoin.

J Res Pharm Pract. 2016 Jan-Mar;5(1):70-3. doi: 10.4103/2279-042X.176560.

New Insights into Drug Reaction with Eosinophilia and Systemic Symptoms Pathophysiology.

Front Med (Lausanne). 2017 Dec 4;4:179. doi: 10.3389/fmed.2017.00179. eCollection 2017.

[DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) syndrome after sulfasalazine and carmazepine: report of two cases].

Rev Med Interne. 2001 Jun;22(6):582-6. doi: 10.1016/s0248-8663(01)00391-5.

Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature.

Pediatr Dermatol. 2020 Jan;37(1):124-129. doi: 10.1111/pde.14044. Epub 2019 Nov 5.

引用本文的文献

Perforation of the descending colon induced by alectinib in a patient with non-small cell lung cancer: a Case Report.

Front Pharmacol. 2025 May 21;16:1545614. doi: 10.3389/fphar.2025.1545614. eCollection 2025.

Alectinib-induced rash unresponsive to desensitization: a case report and literature review.

BMC Pulm Med. 2023 Jul 15;23(1):261. doi: 10.1186/s12890-023-02558-6.

本文引用的文献

Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non-Small Cell Lung Cancer in the Global Phase III ALEX Study.

J Thorac Oncol. 2019 Jul;14(7):1233-1243. doi: 10.1016/j.jtho.2019.03.007. Epub 2019 Mar 20.

Alectinib-Induced Erythema Multiforme and Successful Rechallenge with Alectinib in a Patient with Anaplastic Lymphoma Kinase-Rearranged Lung Cancer.

Case Rep Oncol. 2016 Dec 8;9(3):826-832. doi: 10.1159/000453314. eCollection 2016 Sep-Dec.

Successful oral desensitization against skin rash induced by alectinib in a patient with anaplastic lymphoma kinase-positive lung adenocarcinoma: A case report.

Lung Cancer. 2016 Sep;99:66-8. doi: 10.1016/j.lungcan.2016.06.017. Epub 2016 Jun 23.

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome.

J Clin Aesthet Dermatol. 2013 Jun;6(6):31-7.

DRESS syndrome: Part II. Management and therapeutics.

J Am Acad Dermatol. 2013 May;68(5):709.e1-9; quiz 718-20. doi: 10.1016/j.jaad.2013.01.032.

DRESS syndrome: Part I. Clinical perspectives.

J Am Acad Dermatol. 2013 May;68(5):693.e1-14; quiz 706-8. doi: 10.1016/j.jaad.2013.01.033.

The DRESS syndrome: a literature review.

Am J Med. 2011 Jul;124(7):588-97. doi: 10.1016/j.amjmed.2011.01.017. Epub 2011 May 17.

The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations.

Br J Dermatol. 2007 May;156(5):1083-4. doi: 10.1111/j.1365-2133.2007.07807.x. Epub 2007 Mar 23.

Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

Br J Dermatol. 2007 Mar;156(3):609-11. doi: 10.1111/j.1365-2133.2006.07704.x.

Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS).

Semin Cutan Med Surg. 1996 Dec;15(4):250-7. doi: 10.1016/s1085-5629(96)80038-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验